Fig. 5From: Overcoming the blood–brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approachesSchematic illustration demonstrating the surface modification of nanocarriers with targeting vectors (glucose, L-DOPA, MAbs, and peptides) and the process of the BBB penetrationBack to article page